Form 8-K - Current report:
SEC Accession No. 0001576280-21-000059
Filing Date
2021-05-06
Accepted
2021-05-06 16:17:15
Documents
16
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gh-20210506.htm   iXBRL 8-K 38588
2 EX-99.1 gh-03312021xexhibit991.htm EX-99.1 183827
8 GRAPHIC guardantlogoa011.gif GRAPHIC 17260
  Complete submission text file 0001576280-21-000059.txt   404317

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gh-20210506.xsd EX-101.SCH 2516
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gh-20210506_cal.xml EX-101.CAL 805
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gh-20210506_def.xml EX-101.DEF 1769
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gh-20210506_lab.xml EX-101.LAB 24275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gh-20210506_pre.xml EX-101.PRE 12741
9 EXTRACTED XBRL INSTANCE DOCUMENT gh-20210506_htm.xml XML 10770
Mailing Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063
Business Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 21898024
SIC: 8071 Services-Medical Laboratories